New FDA-Approved Treatment for RKD

The FDA has approved Gazyva® (obinutuzumab) for adults and children ages 2 and older with idiopathic nephrotic syndrome that began in childhood and is frequently relapsing (FRNS) or steroid-dependent (SDNS). More information coming soon. Please visit our Patient Navigation tool for support.

RESOURCES

/

FIND A SPECIALIST

/

CONTACT

COVID-19 Vaccine for Kidney Patients

Answers to your most frequently asked questions on COVID-19 vaccines.

With new updates regarding the COVID-19 vaccine coming out regularly, it’s easy to feel overwhelmed by all the information out there. Together with our COVID-19 Medical Advisory Committee, NephCure has put together a list of answers to your most frequently asked questions when it comes to the COVID-19 vaccine and protein-spilling kidney diseases.

These COVID-19 Vaccine FAQs are designed specifically with the kidney patient and caregiver in mind.

This list of questions and answers is a living document, and we will continue to provide updates to them as more data and information becomes available.

Sign up to get NephCure’s latest updates.

SIGN UP
This field is for validation purposes and should be left unchanged.